ERBB2 and gastric cancer: Indeed, Trastuzumab, a monoclonal antibody for human epidermal growth factor receptor 2 (HER2), has already been established with chemotherapy as a first-line treatment for HER2-positive metastatic advanced GC patients (Bang et al., 2010).